Detalles de la búsqueda
1.
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector.
J Med Chem
; 67(7): 5216-5232, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527911
2.
Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.
J Med Chem
; 60(17): 7371-7392, 2017 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28731719
3.
Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis.
J Med Chem
; 60(9): 3580-3590, 2017 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28414242
4.
Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic.
J Med Chem
; 57(23): 10044-57, 2014 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25380412
5.
Correction to Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2- a]pyridine Series of Autotaxin Inhibitors.
J Med Chem
; 61(9): 4270, 2018 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29672037
Resultados
1 -
5
de 5
1
Próxima >
>>